Clinical Trial Update: Prophylaxis of Diarrhea in Adult Cancer Patients Receiving Targeted Cancer Therapy [Phase 3]

View source ↗

Summary

Phase 3 study evaluating prophylaxis of diarrhea in adult cancer patients receiving targeted cancer therapy. The trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: Napo Pharmaceuticals, Inc. | Conditions: Cancer Therapy-Related Diarrhea, Chemotherapy-related Diarrhea | Phase 3 | Status: COMPLETED